CHICAGO EQUITY PARTNERS LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 196 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHICAGO EQUITY PARTNERS LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$1,765,000
+74.2%
98,120
+71.8%
0.18%
+206.9%
Q4 2019$1,013,000
+107.2%
57,125
+81.3%
0.06%
+152.2%
Q3 2019$489,000
-9.6%
31,5150.0%0.02%
-4.2%
Q2 2019$541,000
+6.7%
31,5150.0%0.02%
+20.0%
Q1 2019$507,000
-56.1%
31,515
-60.1%
0.02%
-57.4%
Q4 2018$1,156,000
+0.7%
78,990
+25.0%
0.05%
+38.2%
Q3 2018$1,148,000
-6.9%
63,200
-13.5%
0.03%
-10.5%
Q2 2018$1,233,000
-73.2%
73,105
-68.9%
0.04%
-74.1%
Q1 2018$4,609,000
-0.4%
235,260
+3.0%
0.15%
+4.3%
Q4 2017$4,628,000
+30.9%
228,440
+12.2%
0.14%
+25.9%
Q3 2017$3,536,000
-12.6%
203,595
-35.5%
0.11%
+2.8%
Q2 2017$4,044,000
+83.5%
315,440
+85.5%
0.11%
+73.0%
Q1 2017$2,204,000
+33.3%
170,030
+1.7%
0.06%
+43.2%
Q4 2016$1,653,000
+62.7%
167,260
+98.9%
0.04%
+57.1%
Q3 2016$1,016,000
+535.0%
84,090
+566.1%
0.03%
+600.0%
Q1 2014$160,000
-18.8%
12,625
-4.0%
0.00%
-33.3%
Q4 2013$197,00013,1500.01%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Third Security, LLC 19,305,403$233,209,00010.86%
BB BIOTECH AG 7,379,832$89,148,0003.13%
SENZAR ASSET MANAGEMENT, LLC 550,544$6,650,572,0001.72%
SNYDER CAPITAL MANAGEMENT L P 2,232,114$26,964,0001.69%
Sterling Global Strategies LLC 22,000$266,0000.98%
IRIDIAN ASSET MANAGEMENT LLC/CT 9,290,024$112,223,0000.98%
MSD Partners, L.P. 965,000$11,657,0000.94%
DOHENY ASSET MANAGEMENT /CA 130,950$1,582,0000.81%
Taylor Wealth Management Partners 128,110$1,548,0000.69%
Bellevue Group AG 318,000$3,841,0000.69%
View complete list of HALOZYME THERAPEUTICS INC shareholders